Farxiga (dapagliflozin) is an oral medication primarily used to: 1. Manage Type 2 Diabetes Mechanism: It’s an SGLT2 (sodium-glucose cotransporter-2) inhibitor. It works by blocking glucose reabsorption in the kidneys, causing excess sugar to be excreted in urine. Effect: Lowers blood sugar levels, reduces HbA1c, and promotes weight loss (typically 2–4 kg). 2. Protect Heart & Kidneys (Key Long-Term Benefits) - Heart Failure - Approved to reduce hospitalization and death in adults with heart failure (both with and without diabetes). - Improves heart function and symptoms like fatigue/swelling. Chronic Kidney Disease (CKD) - Slows kidney damage progression and lowers risk of kidney failure/dialysis in diabetic and non-diabetic CKD patients. Cardiovascular Protection: - Reduces risk of hear...
Farxiga (dapagliflozin) is an oral medication primarily used to: 1. Manage Type 2 Diabetes Mechanism: It’s an SGLT2 (sodium-glucose cotransporter-2) inhibitor. It works by blocking glucose reabsorption in the kidneys, causing excess sugar to be excreted in urine. Effect: Lowers blood sugar levels, reduces HbA1c, and promotes weight loss (typically 2–4 kg). 2. Protect Heart & Kidneys (Key Long-Term Benefits) - Heart Failure - Approved to reduce hospitalization and death in adults with heart failure (both with and without diabetes). - Improves heart function and symptoms like fatigue/swelling. Chronic Kidney Disease (CKD) - Slows kidney damage progression and lowers risk of kidney failure/dialysis in diabetic and non-diabetic CKD patients. Cardiovascular Protection: - Reduces risk of hear...